References
- AbuRuz, S. M., Alrashdan, Y., Jarab, A., Jaber, D., & Alawwa, I. A. (2013). Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan. International Journal of Clinical Pharmacy, 35(5), 780–789. https://doi.org/https://doi.org/10.1007/s11096-013-9806-8
- Aburuz, S., Bulatova, N., Twalbeh, M., & Gazawi, M. (2009). The validity and reliability of the Arabic version of the EQ-5D: A study from Jordan. Annals of Saudi Medicine, 29(4), 304–308. https://doi.org/https://doi.org/10.4103/0256-4947.55313
- Aburuz, S. M., Bulatova, N. R., Yousef, A. M., Al-Ghazawi, M. A., Alawwa, I. A., & Al-Saleh, A. (2011). Comprehensive assessment of treatment related problems in hospitalized medicine patients in Jordan. International Journal of Clinical Pharmacy, 33(3), 501–511. https://doi.org/https://doi.org/10.1007/s11096-011-9497-y
- American Psychiatric Association. (2013). Substance Related Disorders. In C. P. O’Brien & T. J. Crowley (Eds.), Diagnostic and Statistical Manual of Mental Disorders; DSM-V (5th ed., pp. 483–589). American Psychiatric Association.
- American Society of Health-System Pharmacists. (2014). ASHP Statement on the pharmacist’s role in substance abuse prevention, education, and assistance. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists, 71(3), 243–246. https://doi.org/https://doi.org/10.2146/sp140002
- Bale, R. N., Stone, W. W. V., & Kuldau, J. M. (1980). Therapeutic communities vs. methadone maintenance. A prospective study of narcotic addiction treatment: Design and on year followup results. Archives of General Psychiatry, 37(2), 179–193. https://doi.org/https://doi.org/10.1001/archpsyc.1980.01780150069008
- Bastien, C. H., Vallières, A., & Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297–307. https://doi.org/https://doi.org/10.1016/s1389-9457(00)00065-4
- Brocardo, P. S., Boehme, F., Patten, A., Cox, A., Gil-Mohapel, J., & Christie, B. R. (2012). Anxiety- and depression-like behaviors are accompanied by an increase in oxidative stress in a rat model of fetal alcohol spectrum disorders: Protective effects of voluntary physical exercise. Neuropharmacology, 62(4), 1607–1618. https://doi.org/https://doi.org/10.1016/j.neuropharm.2011.10.006
- Chalana, H., Kundal, T., Gupta, V., & Malhari, A. S. (2016). Predictors of relapse after inpatient opioid detoxification during 1-year follow-up. Journal of Addiction, 2016, 7620860. https://doi.org/https://doi.org/10.1155/2016/7620860
- Colvonen, P. J., Ellison, J., Haller, M., & Norman, S. B. (2019). Examining Insomnia and PTSD over time in veterans in residential treatment for substance use disorders and PTSD. Behavioral Sleep Medicine, 17(4), 524–535. https://doi.org/https://doi.org/10.1080/15402002.2018.1425869
- Dimitropoulos, E., Bertucci, S., & Wong, K. (2018). Integration of a clinical pharmacy specialist into a substance use disorder intensive outpatient treatment program to improve prescribing rates of alcohol use disorder pharmacotherapy. Substance Abuse, 39(2), 190–192. https://doi.org/https://doi.org/10.1080/08897077.2018.1449172
- DiPaula, B. A., & Menachery, E. (2015). Physician-pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients. Journal of the American Pharmacists Association: JAPhA, 55(2), 187–192. https://doi.org/https://doi.org/10.1331/JAPhA.2015.14177
- Dodds, C. (2003). Assessing pharmacy interventions at Salisbury Healthcare NHS Trust. Hosp Pharmacist, 19, 415–416.
- Gisev, N., Bell, J. S., O’Reilly, C. L., Rosen, A., & Chen, T. F. (2010). An expert panel assessment of comprehensive medication reviews for clients of community mental health teams. Social Psychiatry and Psychiatric Epidemiology, 45(11), 1071–1079. https://doi.org/https://doi.org/10.1007/s00127-009-0148-8
- Griswold, K. S., Del Regno, P. A., & Berger, R. C. (2015). Recognition and Differential Diagnosis of Psychosis in Primary Care. American Family Physician, 91(12), 856–863
- Harris, A. H., Kivlahan, D., Barnett, P. G., & Finney, J. W. (2012). Longer length of stay is not associated with better outcomes in VHA’s substance abuse residential rehabilitation treatment programs. The Journal of Behavioral Health Services & Research, 39(1), 68–79. https://doi.org/https://doi.org/10.1007/s11414-011-9250-2
- Hartwell, K. J.,Tolliver, B. K., &Brady, K. T. (2009). Biologic Commonalities between Mental Illness and Addiction. Primary Psychiatry. 1; 16(8): 33–39.PMID:26030747
- Hiller, M. L., Knight, K., & Simpson, D. D. (2006). Recidivism following mandated residential substance abuse treatment for felony probationers. The Prison Journal, 86(2), 230–241. https://doi.org/https://doi.org/10.1177/0032885506287951
- Huang, K., Zhang, L., & Liu, J. (2011). Drug problems in contemporary China: A profile of Chinese drug users in a metropolitan area. The International Journal on Drug Policy, 22(2), 128–132. https://doi.org/https://doi.org/10.1016/j.drugpo.2010.09.010
- Husseini, R. (2012). Prevention key to combating drug abuse. The Jordan Times.
- Jansson, I., Hesse, M., & Fridell, M. (2009). Influence of personality disorder features on social functioning in substance-abusing women five years after compulsive residential treatment. European Addiction Research, 15(1), 25–31. https://doi.org/https://doi.org/10.1159/000173006
- Lynch, W. J., Peterson, A. B., Sanchez, V., Abel, J., & Smith, M. A. (2013). Exercise as a novel treatment for drug addiction: A neurobiological and stage-dependent hypothesis. Neuroscience and Biobehavioral Reviews, 37(8), 1622–1644. https://doi.org/https://doi.org/10.1016/j.neubiorev.2013.06.011
- Machin, D., Campbell, M. J., Tan, S. B., & Tan, S. H. (2008). Sample Size Tables for Clinical Studies. First published:21 November 2008Print ISBN:9781405146500 |Online ISBN:9781444300710 |DOI:https://doi.org/10.1002/9781444300710
- Mahfoud, Y., Talih, F., Streem, D., & Budur, K. (2009). Sleep disorders in substance abusers: how common are they?Psychiatry (Edgmont (PA: Township)), 6(9), 38–42.
- NIDA. (2018). Drugs, brains, and behavior: The science of addiction. Retrieved from https://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery
- NIDA. (2019). Treatment approaches for drug addiction drugfacts. Retrieved from https://www.drugabuse.gov/publications/drugfacts/treatment-approaches-drug-addiction on 2021, July 26
- Ouimette, P. C., Finney, J. W., & Moos, R. H. (1997). Twelve-step and cognitive–behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology, 65(2), 230–240. doi:https://doi.org/10.1037//0022-006x.65.2.230
- Ourth, H., Groppi, J., Morreale, A. P., & Quicci-Roberts, K. (2016). Clinical pharmacist prescribing activities in the Veterans Health Administration. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists, 73(18), 1406–1415. https://doi.org/https://doi.org/10.2146/ajhp150778
- Peak, J., Goranitis, I., Day, E., Copello, A., Freemantle, N., & Frew, E. (2018). Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP. Health and Quality of Life Outcomes, 16(1), 106. https://doi.org/https://doi.org/10.1186/s12955-018-0926-7
- Ray, L. A., Meredith, L. R., Kiluk, B. D., Walthers, J., Carroll, K. M., & Magill, M. (2020). Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: A systematic review and meta-analysis. JAMA Netw Open, 3(6), e208279. https://doi.org/https://doi.org/10.1001/jamanetworkopen.2020.8279
- Richardson, T. E., O’Reilly, C. L., & Chen, T. F. (2014). A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health. International Journal of Clinical Pharmacy, 36(2), 222–232. https://doi.org/https://doi.org/10.1007/s11096-013-9900-y
- Rochefoucauld, M. D L. (2014). Jordan: Drug situation and policy. Retrieved from https://rm.coe.int/drug-situation-and-policy-by-matthieu-de-la-rochefoucauld/168075f2a7
- Ruglass, L. M., Scodes, J., Pavlicova, M., Campbell, A. N. C., Fitzpatrick, S., Barbosa-Leiker, C., Burlew, K., Greenfield, S. F., Rotrosen, J., & Nunes, E. V.Jr. (2019). Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone. Drug and Alcohol Dependence, 205, 107649. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2019.107649
- SAMHSA. (2006). Detoxification and Substance Abuse Treatment. In Treatment Improvement Protocol (TIP) series. No. 45. Center for Substance Abuse Treatment. Report No.: (SMA) 06–4131
- Shwartz, M., Mulvey, K. P., Woods, D., Brannigan, P., & Plough, A. (1997). Length of stay as an outcome in an era of managed care: An Empirical Study. Journal of Substance Abuse Treatment, 14(1), 11–18. https://doi.org/https://doi.org/10.1016/S0740-5472(96)00095-5
- Smith, M. A., & Lynch, W. J. (2011). Exercise as a potential treatment for drug abuse: Evidence from preclinical studies. Frontiers in Psychiatry, 2, 82. https://doi.org/https://doi.org/10.3389/fpsyt.2011.00082
- Strauss, S. M., & Falkin, G. P. (2001). The first week after drug treatment: The influence of treatment on drug use among women offenders. The American Journal of Drug and Alcohol Abuse, 27(2), 241–264. https://doi.org/https://doi.org/10.1081/ada-100103708
- Suleiman, K. H., & Yates, B. C. (2011). Translating the Insomnia severity index into Arabic. Journal of Nursing Scholarship, 43(1), 49–53. https://doi.org/https://doi.org/10.1111/j.1547-5069.2010.01374.x
- Tang, J., Liao, Y., He, H., Deng, Q., Zhang, G., Qi, C., Cui, H., Jiao, B., Yang, M., Feng, Z., Chen, X., Hao, W., & Liu, T. (2015). Sleeping problems in Chinese illicit drug dependent subjects. BMC Psychiatry, 15, 28. https://doi.org/https://doi.org/10.1186/s12888-015-0409-x
- UNODC. (2012). World Drug Report 2012. Retrieved from Vienna: https://www.unodc.org/unodc/en/data-and-analysis/WDR-2012.html
- Vaughn, M. S., Deng, F., & Lee, L.-J. (2003). Evaluating a prison-based drug treatment program in Taiwan. Journal of Drug Issues, 33(2), 357–383. https://doi.org/https://doi.org/10.1177/002204260303300205
- Volkow, N. (2020). Personalizing the treatment of substance use disorders. The American Journal of Psychiatry, 177(2), 113–116. https://doi.org/https://doi.org/10.1176/appi.ajp.2019.19121284
- Wang, I., Dopheide, J. A., & Gregerson, P. (2011). Role of a psychiatric pharmacist in a Los Angeles "Skid-Row" safety-net clinic. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 88(4), 718–723. https://doi.org/https://doi.org/10.1007/s11524-011-9573-6
- WHO. (2010). ATLAS of substance use disorders: Resources for the prevention and treatment of Substance Use Disorders (SUD). Retrieved from https://www.who.int/substance_abuse/publications/atlas_report/profiles/jordan.pdf?ua=1
- WHO. (2018). Global status report on alcohol and health 2018. Retrieved from https://www.who.int/publications-detail-redirect/9789241565639
- Wilkerson, A. K., Sahlem, G. L., Bentzley, B. S., Lord, J., Smith, J. P., Simmons, R. O., Uhde, T. W., & Book, S. W. (2019). Insomnia severity during early abstinence is related to substance use treatment completion in adults enrolled in an intensive outpatient program. Journal of Substance Abuse Treatment, 104, 97–103. https://doi.org/https://doi.org/10.1016/j.jsat.2019.06.003
- World Health Organization. (2010). ATLAS of substance use disorders, resources for the prevention and treatment of Substance Use Disorders (SUD), Country Profile: JORDAN. Retrieved from https://www.who.int/substance_abuse/publications/atlas_report/profiles/jordan.pdf?ua=1
- Yasin, H., Bulatova, N., & Wazaify, M. (2020). Patterns of substance use among patients in addiction rehabilitation in Jordan. Substance Use & Misuse, 55(7), 1035–1044. https://doi.org/https://doi.org/10.1080/10826084.2020.1722697